Athersys
ATHX
$0.01350
Share price
-33.50%
Change (1 day)
-98.90%
Change (1 year)
Categories
Athersys (ATHX) - P/B ratio
P/B ratio as of April 2024 : -0.0229
According to Athersys's latest financial reports the company has a price-to-book ratio of -0.0229.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Athersys - P/B ratio (from 2007 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -0.0339 | -94.4% |
| 2022-12-31 | -0.6061 | -104.67% |
| 2021-12-31 | 13.0 | 15.09% |
| 2020-12-31 | 11.3 | 33.44% |
| 2019-12-31 | 8.45 | 75.26% |
| 2018-12-31 | 4.82 | -47.49% |
| 2017-12-31 | 9.18 | -21.83% |
| 2016-12-31 | 11.7 | 168.55% |
| 2015-12-31 | 4.37 | -25.6% |
| 2014-12-31 | 5.88 | -34.09% |
| 2013-12-31 | 8.92 | 220.95% |
| 2012-12-31 | 2.78 | -50.14% |
| 2011-12-31 | 5.57 | 7.3% |
| 2010-12-31 | 5.19 | 25.91% |
| 2009-12-31 | 4.12 | 1427.85% |
| 2008-12-31 | 0.2699 | -86.17% |
| 2007-12-31 | 1.95 | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.12 | -22,465.80% | 🇺🇸 USA |
 Pfizer PFE | 1.61 | -7,133.50% | 🇺🇸 USA |
 Amgen AMGN | 23.2 | -101,600.00% | 🇺🇸 USA |
 Sanofi SNY | 1.49 | -6,627.32% | 🇫🇷 France |
 Merck MRK | 8.83 | -38,669.19% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 3.09 | -13,577.04% | 🇺🇸 USA |
 Moderna
MRNA | 2.98 | -13,132.94% | 🇺🇸 USA |